Sicily study tests how two bTB surveillance tools align

Bottom line

A new study from Sicily suggests that the intradermal tuberculin test and the interferon-gamma release assay still track reasonably well in field surveillance for bovine tuberculosis, but their agreement may weaken as eradication efforts move into more complex, higher-risk settings. Researchers from the University of Palermo evaluated 1,801 cattle from 44 herds in Palermo province during 2024–2025, a period that overlapped with Italy’s updated national eradication procedures issued on May 2, 2024. They found high observed agreement between the two tests in both years, with Cohen’s kappa falling from substantial agreement in 2024 (0.731) to moderate agreement in 2025 (0.453). The paper adds fresh field data from a part of southern Italy where bovine tuberculosis remains endemic and surveillance decisions carry regulatory and trade consequences. (mdpi.com)

Why it matters: For veterinary professionals, the study is a reminder that test concordance can shift with local epidemiology, herd status, and program design. Italy’s national control framework uses intradermal testing as the backbone of surveillance, with interferon-gamma used in defined situations to strengthen detection, especially in non-free territories. That matters because IFN-γ can help identify infected animals earlier, but like any ancillary test, it changes the balance between sensitivity and specificity. In endemic areas, that tradeoff affects follow-up testing, culling decisions, movement controls, slaughter surveillance, and conversations with producers about why one animal may test differently across methods. (salute.gov.it)

What to watch: Watch for whether Sicily’s 2025–2027 eradication measures and Italy’s updated national program lead to broader operational use of IFN-γ in infected clusters, or more refined rules for when discordant results trigger action. (regione.sicilia.it)

Key facts

Study topic
Agreement between the intradermal tuberculin test and the interferon-gamma release assay for bovine tuberculosis surveillance
Study location
Palermo province, Sicily, Italy
Sample size
1,801 cattle from 44 herds
Study period
2024–2025
Key finding
Observed agreement was high in both years, but Cohen’s kappa fell from 0.731 in 2024 to 0.453 in 2025
Interpretation
Agreement shifted from substantial in 2024 to moderate in 2025
National program context
Italy’s updated bovine and buffalo tuberculosis eradication program was adopted on 2024-05-02
Publication
Veterinary Sciences, August 2026

A newly published field study from Sicily offers a timely look at how two cornerstone bovine tuberculosis surveillance tools perform side by side in an endemic setting. In 1,801 cattle from 44 herds in Palermo province during 2024–2025, researchers found that the intradermal tuberculin test, or IDT, and the interferon-gamma release assay, or IFN-γ, showed high observed agreement overall, but statistical agreement weakened from 2024 to 2025. Specifically, Cohen’s kappa dropped from 0.731, considered substantial, to 0.453, considered moderate. The study was published in Veterinary Sciences in August 2026. (mdpi.com)

That timing matters. The surveillance period coincided with Italy’s updated national bovine and buffalo tuberculosis eradication program, adopted by ministerial decree on May 2, 2024. Under that framework, intradermal tuberculin testing remains the core immunologic screening tool, while gamma-interferon testing is used in specific circumstances, particularly in non-free areas and higher-risk investigations. Sicily has long been one of the more challenging regions for eradication, and regional authorities later issued a 2025–2027 decree targeting brucellosis and bovine tuberculosis in infection clusters. (mdpi.com)

The new paper draws on surveillance data retrieved from Italy’s VETINFO veterinary information system through the Palermo local health authority. It also incorporates post-mortem lesion detection at slaughter, aligning the live-animal testing picture with abattoir surveillance. According to the study summary, observed agreement between IDT and IFN-γ was 0.967 in 2024 and 0.909 in 2025, indicating that the tests still matched in most animals even as kappa declined. That pattern suggests the changing agreement may reflect shifts in prevalence, case mix, or the types of herds being tested, rather than a simple breakdown in either assay. That last point is an inference based on the reported statistics and the known behavior of kappa in different prevalence settings. (mdpi.com)

The broader literature helps explain why this comparison matters. Reviews and field studies have consistently described IFN-γ as a useful adjunct because it can detect cellular immune responses earlier than skin testing alone and can increase overall case finding when used in parallel. At the same time, performance depends heavily on cutoffs, epidemiologic context, and the operational goal, whether that’s maximizing sensitivity in infected herds or preserving specificity in low-prevalence populations. Recent European work has emphasized that IFN-γ has mostly been used in infected farms alongside skin testing to increase detection, while earlier reviews noted that all ante-mortem bTB tests involve tradeoffs between false positives and false negatives. (pubmed.ncbi.nlm.nih.gov)

I didn’t find direct outside commentary on this specific Sicily paper yet, which isn’t surprising given that it was published only days ago. But the industry and regulatory context points in the same direction: Italy continues to treat bTB eradication as an active national priority, and official materials describe gamma-interferon as part of the surveillance toolbox in non-free territories. EU outbreak reporting also shows Italy continued to report Mycobacterium tuberculosis complex events in 2025, underscoring that this remains a live disease-control issue rather than a historical one. (salute.gov.it)

Why it matters: For veterinary professionals, this study is less about declaring a winner between IDT and IFN-γ than about understanding how test agreement behaves under real program conditions. In endemic regions, discordant results aren’t just academic. They shape herd restrictions, retest strategies, slaughter decisions, compensation pathways, trace investigations, and producer trust in the surveillance system. For practitioners advising dairy or beef operations, the study reinforces that test interpretation has to be anchored in herd history, local prevalence, regulatory rules, and the purpose of testing. A moderate kappa does not mean the assays are unusable; it means parallel testing may be surfacing different parts of the infection spectrum. (mdpi.com)

There’s also a practical lesson here for conversations with pet parents and the public around food systems and zoonotic disease control. Bovine tuberculosis surveillance is designed not only to protect herd health and trade status, but also to reduce zoonotic risk. Earlier work from Sicily has highlighted both the economic burden and the public health rationale for aggressive test-and-slaughter programs in southern Italy, with slaughterhouse inspection serving as an important backstop to field testing. (pmc.ncbi.nlm.nih.gov)

What to watch: The next signal will be whether Italian and Sicilian authorities translate findings like these into more explicit field guidance on when to deploy IFN-γ, how to handle discordant IDT/IFN-γ results, and whether cluster-based eradication plans from 2025 through 2027 improve consistency between live-animal testing and post-mortem confirmation. (regione.sicilia.it)

How this developed

  1. Italy adopted an updated national bovine and buffalo tuberculosis eradication program.

  2. Researchers collected surveillance data from cattle in Palermo province and found Cohen’s kappa of 0.731.

  3. Researchers continued surveillance and found Cohen’s kappa had fallen to 0.453.

  4. Sicilian authorities issued a decree targeting brucellosis and bovine tuberculosis in infection clusters.

  5. The study was published in Veterinary Sciences.

Common questions

  • What did the study find about the two tests?
    The intradermal tuberculin test and the interferon-gamma release assay still showed high observed agreement, but statistical agreement weakened from 2024 to 2025.
  • How many cattle and herds were included?
    The researchers evaluated 1,801 cattle from 44 herds.
  • Where was the study done?
    In Palermo province, Sicily, Italy.
  • Why does this matter for surveillance?
    Italy uses intradermal testing as the core screening tool, with interferon-gamma used in specific higher-risk situations, so changing agreement can affect follow-up testing and control decisions.

Like what you're reading?

The Feed delivers veterinary news every weekday.